Lung Cancer Remains Top Cancer Killer as Screening Gaps Persist

Lung cancer remains the leading cause of cancer death in the United States, and most cases are still caught late, when treatment is harder, more expensive, and less likely to succeed. That reality sits at the center of several pressures health systems are already managing, according to Becker's Hospital Review: an aging patient population, uneven access to screening, and large gaps in outcomes depending on where a patient lives.

In practice, the burden on a given system depends heavily on geography and screening capacity. Where low-dose CT screening programs reach high-risk patients early, more cancers are found at treatable stages. Where they do not, patients arrive later and at higher cost.

For leaders, the takeaway is operational as much as clinical. Closing screening gaps, standardizing follow-up on suspicious findings, and extending access into underserved areas are concrete levers to shift detection earlier and improve both survival and the economics of care.